Simplex Trading’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1
Closed -$6K 8422
2019
Q3
$6K Hold
1
﹤0.01% 6577
2019
Q2
$5K Sell
1
-9
-90% -$533 ﹤0.01% 6498
2019
Q1
$70K Sell
10
-10
-50% -$741 ﹤0.01% 4714
2018
Q4
$128K Buy
20
+18
+900% +$1.26K ﹤0.01% 3612
2018
Q3
$14K Buy
+2
New +$117 ﹤0.01% 6251
2015
Q4
Sell
-10
Closed -$3K 6490
2015
Q3
$3K Buy
10
+4
+67% +$103 ﹤0.01% 4481
2015
Q2
$7K Hold
6
﹤0.01% 3436
2015
Q1
$6K Buy
+6
New +$191 ﹤0.01% 3420

Simplex Trading's GHDX Position: Q3 2019 in Review

Simplex Trading sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 5 shares — an estimated $343 sold.

Simplex Trading first reported a position in GHDX in Q1 2015 and held it in 12 quarters. The position peaked at $230K in Q4 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Simplex Trading reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Simplex Trading sold 5 Genomic Health, Inc. shares in Q3 2019, an estimated $343.
  • Simplex Trading first reported a position in Genomic Health, Inc. in Q1 2015 and held it in 12 quarters.
  • Simplex Trading's Genomic Health, Inc. position peaked at $230K in Q4 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.